← back to search

Niels Viggo Jensen

Rigshospitalet · DK
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, Cancer Genomics and Diagnostics, and Cancer Immunotherapy and Biomarkers.
h-index
14
citations
1,286
works
53
NIH funding
primary concept
Medicine
email

Recent publications

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
The Lancet Oncology 2019cited by 84position: middledoi
Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma
European Journal of Cancer 2019cited by 26position: middledoi
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
The Lancet 2017cited by 177position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Éric Voog · Centre Jean Bernard1 papers (2019–2019) · 1 papers (2019–2019)Carsten Grüllich · Sana Klinikum1 papers (2019–2019)Sylvie Négrier · Université Claude Bernard Lyon 11 papers (2019–2019)Elizabeth Hovey · Victorian Comprehensive Cancer Centre1 papers (2019–2019) · 1 papers (2019–2019)Sumanta K. Pal · City of Hope1 papers (2019–2019)Reinhard Depenbusch · Praxis für Hämatologie und Onkologie1 papers (2019–2019)Bernard Escudier · Institut Gustave Roussy1 papers (2019–2019)Toni K. Choueiri · Harvard University1 papers (2019–2019)Robert J. Motzer · Texas Oncology1 papers (2019–2019)Frede Donskov · Aarhus University Hospital1 papers (2019–2019)Katharine Cuff · Princess Alexandra Hospital1 papers (2019–2019)Lothar Bergmann · University Hospital Frankfurt1 papers (2019–2019)Thomas Powles · National Health Service1 papers (2019–2019) · 1 papers (2019–2019)Christine Chevreau · Institut Claudius Regaud1 papers (2019–2019) · 1 papers (2019–2019)